MedPath

Arsanis, Inc.

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.arsanis.com

Clinical Trials

12

Active:9
Completed:0

Trial Phases

2 Phases

Phase 1:9
Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Phase 1
9 (75.0%)
Phase 2
3 (25.0%)

Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.

Phase 2
Terminated
Conditions
Pneumonia, Ventilator-associated
Pneumonia, Staphylococcal
Interventions
Drug: Placebo
First Posted Date
2016-10-21
Last Posted Date
2019-07-31
Lead Sponsor
Arsanis, Inc.
Target Recruit Count
155
Registration Number
NCT02940626
Locations
🇺🇦

Research Site, Lviv, Ukraine

🇦🇹

Research Site 040-001, Wien, Austria

🇦🇹

Research Site 040-002, Wien, Austria

and more 16 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.